Pete Stark

Articles by Pete Stark

Latest Updated Articles

Trending on PharmExec

FDA Approves Subcutaneous Induction for Skyrizi in Crohn's Disease

Treasury Proposes Rules Adding Biotechnology to Outbound Investment Security Program

Roundup: Gilead Acquires Oral IL-23R Inhibitor From PepStar for $1.275 Billion, Zymeworks Licenses DLL3-Targeting T Cell Engager to Roche

FDA Approves Hibsago (Bepirovirsen) for Chronic Hepatitis B

Pharmaceutical Executive Daily: FDA Approves Hibsago